tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Income Statement

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Income Statement

Last quarter (Q1 2025), Immuno-Biological Laboratories Co., Ltd.'s total revenue was ¥211.48M, a decrease of -7.65% from the same quarter last year. In Q1, Immuno-Biological Laboratories Co., Ltd.'s net income was ¥60.95M. See Immuno-Biological Laboratories Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M¥ 602.75M
Gross Profit
¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M¥ 346.86M
Operating Expenses
¥ 419.00M¥ 412.99M¥ 468.33M¥ 498.91M¥ 587.83M
Depreciation and Amortization
¥ 15.43M¥ 2.33M¥ -52.00M¥ 0.00¥ 0.00
EBITDA
¥ 226.55M¥ 128.11M¥ -332.00M¥ -249.50M¥ -309.88M
Operating Income
¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M¥ -240.98M
Other Income/Expenses
¥ 515.00K¥ 20.34M¥ -338.98M¥ -127.92M¥ -69.65M
Pretax Income
¥ 209.86M¥ 124.64M¥ -280.61M¥ -250.14M¥ -310.63M
Net Income
¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M¥ -318.83M
Per Share Metrics
Basic EPS
¥ 26.74¥ 20.05¥ -31.11¥ -27.78¥ -34.23
Diluted EPS
¥ 26.74¥ 20.05¥ -31.11¥ -27.78¥ -34.23
Weighted Average Shares Outstanding
9.31M 9.31M 9.31M 9.31M 9.31M
Weighted Average Shares Outstanding (Diluted)
9.31M 9.31M 9.31M 9.31M 9.31M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History